Medical technology company Sensodetect will be delisted from Spotlight Stock Market after the company did not pay the sanction fee previously decided by the market venue's disciplinary board. The last trading day in the share will be June 12.The company states that the strained liquidity and financing situation has meant that available resources have needed to be prioritized to ensure the continued operations. According to CEO Per-Anders Hedin, work continues on financing solutions, cost adjustments, commercialization and international collaborations. "The delisting is naturally regrettable. At the same time, our focus remains on handling the financial situation in a responsible manner, implementing the measures required and creating conditions for the Company's continued operations. We also continue the work on our ongoing business activities and international initiatives", says Per-Anders Hedin, CEO of Sensodetect.